Patent details

EP2791160 Title: MODIFIED MRNA COMPOSITIONS

Basic Information

Publication number:
EP2791160
PCT Application Number:
US2012069610
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP128583507
PCT Publication Number:
WO2013090648
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MODIFIED MRNA COMPOSITIONS
French Title of Invention:
COMPOSITIONS DE MRNA MODIFIÉS
German Title of Invention:
MODIFIZIERTE MRNA ZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
14/12/2012
Grant date:
02/03/2022
EP Publication Date:
22/10/2014
PCT Publication Date:
20/06/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/03/2022
EP B1 Publication Date:
02/03/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/12/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/06/2024
 
 

Name:
ModernaTX, Inc.
Address:
325 Binney Street, Cambridge, MA 02142, United States (US)

History of Owners

From:
13/06/2024
To:
13/06/2024

Name:
ModernaTX, Inc.
Address:
325 Binney Street, Cambridge, MA 02142, United States (US)

From:
23/02/2022
To:
13/06/2024

Name:
ModernaTX, Inc.
Address:
200 Technology Square, Cambridge, MA 02139, United States (US)

Agent

Name:
STOLMÁR & PARTNER
From:
01/06/2022
Address:
BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
ELBASHIR, Sayda M.
Address:
United States (US)

2

Name:
VALENCIA, Pedro
Address:
United States (US)

3

Name:
SCHRUM, Jason P.
Address:
United States (US)

4

Name:
AFEYAN, Noubar B.
Address:
United States (US)

5

Name:
DE FOUGEROLLES, Antonin
Address:
Belgium (BE)

6

Name:
WOOD, Kristy M.
Address:
United States (US)

Priority

1

Priority Number:
201161576705 P
Priority Date:
16/12/2011
Priority Country:
United States (US)

2

Priority Number:
201261618957 P
Priority Date:
02/04/2012
Priority Country:
United States (US)

3

Priority Number:
201261648244 P
Priority Date:
17/05/2012
Priority Country:
United States (US)

4

Priority Number:
201261681712 P
Priority Date:
10/08/2012
Priority Country:
United States (US)

5

Priority Number:
201261696381 P
Priority Date:
04/09/2012
Priority Country:
United States (US)

6

Priority Number:
PCT/US2012/058519
Priority Date:
03/10/2012
Priority Country:
World Intellectual Property Office (WIPO) (WO)

7

Priority Number:
201261709303 P
Priority Date:
03/10/2012
Priority Country:
United States (US)

8

Priority Number:
201261712490 P
Priority Date:
11/10/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 48/00; C07K 14/47; C12N 15/85; A61K 31/7115; C12N 9/88; A61K 9/00; A61K 9/127; A61K 9/14; A61K 9/16; A61K 31/7088; C07K 2/00; C12N 15/117; C12P 21/00; A61K 31/7105; C12N 15/88; C12N 15/00; A61P 3/00; A61P 3/10; A61P 9/10;

Publication

European Patent Bulletin

1

Issue number:
202209
Publication date:
02/03/2022
Description:
Grant (B1)

2

Issue number:
202244
Publication date:
02/11/2022
Description:
Opposition procedure started

3

Issue number:
202231
Publication date:
03/08/2022
Description:
Opposition procedure started

4

Issue number:
202225
Publication date:
22/06/2022
Description:
Opposition procedure started

5

Issue number:
202214
Publication date:
06/04/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

6

Issue number:
202429
Publication date:
17/07/2024
Description:
Change of owner's name or address

7

Issue number:
202429
Publication date:
17/07/2024
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
28/11/2024
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
01/06/2022 Power Of Attorney 1
01/06/2022 Outgoing Correspondence 1